Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (15)

2014

  1. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

    Epilepsia, Vol. 55, Núm. 6, pp. 791-802

  2. Estrategias de neuroprotección en el recién nacido

    Anales de Pediatria Continuada, Vol. 12, Núm. 2, pp. 85-89

2013

  1. Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?

    British Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 323-333

  2. Cannabinoids: Well-Suited candidates for the treatment of perinatal brain injury

    Brain Sciences, Vol. 3, Núm. 3, pp. 1043-1059

  3. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT1A and CB2 receptors

    Neuropharmacology, Vol. 71, pp. 282-291

2012

  1. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors

    British Journal of Pharmacology, Vol. 166, Núm. 4, pp. 1474-1489

2011

  1. Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs

    Pediatric Research, Vol. 70, Núm. 3, pp. 272-277

  2. Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: An intravital microscopy study

    Journal of Neuroinflammation, Vol. 8

2010

  1. The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia

    Stroke, Vol. 41, Núm. 12, pp. 2956-2964

  2. The cannabinoid receptor agonist WIN 55,212-2 reduces the initial cerebral damage after hypoxic-ischemic injury in fetal lambs

    Brain Research, Vol. 1362, pp. 150-159

  3. The endocannabinoid system and amyloid-related diseases

    Experimental Neurology, Vol. 224, Núm. 1, pp. 66-73

  4. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors

    Neurobiology of Disease, Vol. 37, Núm. 2, pp. 434-440

2009

  1. Cannabinoids and neurodegenerative diseases

    CNS and Neurological Disorders - Drug Targets, Vol. 8, Núm. 6, pp. 440-450

1998

  1. Endothelial factors and autoregulation during pressure changes in isolated newborn piglet cerebral arteries

    Pediatric Research, Vol. 44, Núm. 2, pp. 161-167

1996

  1. Impairment of acetylcholine relaxations by malondialdehyde, a marker of lipid peroxidation

    Journal of Vascular Research, Vol. 33, Núm. 6, pp. 463-470